Edison Ophthalmology Associates has been investing in disruptive healthcare technology-enabled services and life sciences companies for over 25 years, offering top quartile returns through its early/growth stage partnership model. With a proven track record of successfully building durable, valuable companies throughout multiple business cycles, Cardinal Partners is well-positioned to be a leading next-generation venture capital firm in the healthcare industry.